Albertans affected or at moderate to high risk for a hereditary cancer syndrome determined through a genetic risk evaluation of the individual's medical and family history
Unaffected Individuals
Individuals unaffected by cancer are usually not eligible for genetic testing except where a mutation is known in the family
Known Familial Mutation
Individuals or relatives of an individual with a confirmed pathogenic or likely pathogenic mutation in hereditary cancer gene
Breast Cancer
1.Personal history of breast cancer diagnosed≤35
§2.Personal history of two breast primaries, both diagnosed≤60 OR at least one diagnosed≤50
§
3.Personal history of breast and ovarian cancer*
§4.Personal history of breast and pancreatic cancer
§
5.Personal history of breast cancer≤50 AND family history of breast cancer≤50
6.Personal history of breast cancer AND family history of ovarian cancer* diagnosed at any age
7.Personal history of breast cancer AND 2 family members with breast cancer; one diagnosed ≤50
8.Personal history of breast cancer AND 2 family members with pancreatic adenocarcinoma at any age
§9.Personal history of triple negative breast cancer (ER-ve, PR-ve, Her2-ve) diagnosed ≤65
§10.Personal history of male breast cancer diagnosed at any age
§11.Personal history of breast cancer and family history of male breast cancer
12.Personal history of breast cancer at any age and a first degree relative meeting a “§”criterion
§Ovarian Cancer
1. Personal history of invasive epithelial ovarian/fallopian tube/primary peritoneal cancer at any age
§ §Mainstreaming criteria;patient meeting these criteria can have genetic testing ordered through approved surgeon/oncologists
Pancreatic Cancer
1.Personal history of pancreatic adenocarcinoma at any age AND ≥2 relatives with breast/ovarian/pancreatic cancer at any age
Ashkenazi Jewish Families
1.Personal history of breast or ovarian cancer* at any age
2.Unaffected individuals with a 1st or 2nd-degree relative with breast/ovarian cancer* at any age
Familial Adenomatous Polyposis (FAP) and other polyposis syndromes
1.Suspected or known diagnosis of FAP or other polyposis syndrome in patient or close relative
2.Personal history of ≥10 polyps (adenomatous, hamartomatous)
Lynch Syndrome (Hereditary Non-Polyposis Colorectal Cancer)
1.Patients meeting Amsterdam I or II Criteria.
a. 3 affected family members (colon, uterus, stomach, small intestine, ovary, pancreas, gallbladder, transitional cell cancer of renal pelvis/ureter/bladder) AND
b. 1 cancer diagnosis ≤50 years AND
c. 2 successive generations
2.Any patient with abnormal immunohistochemistry (IHC) and/or microsatellite instability (MSI) results suggestive of Lynch syndrome
3.Patients meeting
Bethesda Criteria (or those with family histories meeting these criteria) may be referred for IHC testing and/or MSI testing on the tumours from the affected family members
Bethesda Criteria include:
- CRC or endometrial cancer ≤50 years
- Synchronous or metachronous Lynch syndrome cancers at any age
- CRC in a patient with a 1st degree relative with a Lynch syndrome tumour; one diagnosis ≤50
- CRC in a patient with two 1st or 2nd degree relatives with Lynch syndrome tumours diagnosed at any age
Albertans affected or at moderate to high risk for a hereditary cancer syndrome determined through a genetic risk evaluation of the individual's medical and family history
Unaffected Individuals
Individuals unaffected by cancer are usually not eligible for genetic testing except where a mutation is known in the family
Known Familial Mutation
Individuals or relatives of an individual with a confirmed pathogenic or likely pathogenic mutation in hereditary cancer gene
Breast Cancer
1.Personal history of breast cancer diagnosed≤35
§2.Personal history of two breast primaries, both diagnosed≤60 OR at least one diagnosed≤50
§
3.Personal history of breast and ovarian cancer*
§4.Personal history of breast and pancreatic cancer
§
5.Personal history of breast cancer≤50 AND family history of breast cancer≤50
6.Personal history of breast cancer AND family history of ovarian cancer* diagnosed at any age
7.Personal history of breast cancer AND 2 family members with breast cancer; one diagnosed ≤50
8.Personal history of breast cancer AND 2 family members with pancreatic adenocarcinoma at any age
§9.Personal history of triple negative breast cancer (ER-ve, PR-ve, Her2-ve) diagnosed ≤65
§10.Personal history of male breast cancer diagnosed at any age
§11.Personal history of breast cancer and family history of male breast cancer
12.Personal history of breast cancer at any age and a first degree relative meeting a “§”criterion
§Ovarian Cancer
1. Personal history of invasive epithelial ovarian/fallopian tube/primary peritoneal cancer at any age
§ §Mainstreaming criteria;patient meeting these criteria can have genetic testing ordered through approved surgeon/oncologists
Pancreatic Cancer
1.Personal history of pancreatic adenocarcinoma at any age AND ≥2 relatives with breast/ovarian/pancreatic cancer at any age
Ashkenazi Jewish Families
1.Personal history of breast or ovarian cancer* at any age
2.Unaffected individuals with a 1st or 2nd-degree relative with breast/ovarian cancer* at any age
Familial Adenomatous Polyposis (FAP) and other polyposis syndromes
1.Suspected or known diagnosis of FAP or other polyposis syndrome in patient or close relative
2.Personal history of ≥10 polyps (adenomatous, hamartomatous)
Lynch Syndrome (Hereditary Non-Polyposis Colorectal Cancer)
1.Patients meeting Amsterdam I or II Criteria.
a. 3 affected family members (colon, uterus, stomach, small intestine, ovary, pancreas, gallbladder, transitional cell cancer of renal pelvis/ureter/bladder) AND
b. 1 cancer diagnosis ≤50 years AND
c. 2 successive generations
2.Any patient with abnormal immunohistochemistry (IHC) and/or microsatellite instability (MSI) results suggestive of Lynch syndrome
3.Patients meeting
Bethesda Criteria (or those with family histories meeting these criteria) may be referred for IHC testing and/or MSI testing on the tumours from the affected family members
Bethesda Criteria include:
- CRC or endometrial cancer ≤50 years
- Synchronous or metachronous Lynch syndrome cancers at any age
- CRC in a patient with a 1st degree relative with a Lynch syndrome tumour; one diagnosis ≤50
- CRC in a patient with two 1st or 2nd degree relatives with Lynch syndrome tumours diagnosed at any age
More
Less